Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
EXPO

EXPO - Exponent Inc Stock Price, Fair Value and News

94.25USD-0.21 (-0.22%)Delayed

Market Summary

EXPO
USD94.25-0.21
Delayed
-0.22%

EXPO Alerts

  • 3 major insider sales recently.

EXPO Stock Price

View Fullscreen

EXPO RSI Chart

EXPO Valuation

Market Cap

4.8B

Price/Earnings (Trailing)

47.22

Price/Sales (Trailing)

8.84

EV/EBITDA

30.78

Price/Free Cashflow

36.17

EXPO Price/Sales (Trailing)

EXPO Profitability

EBT Margin

26.00%

Return on Equity

27.08%

Return on Assets

16.1%

Free Cashflow Yield

2.76%

EXPO Fundamentals

EXPO Revenue

Revenue (TTM)

541.4M

Rev. Growth (Yr)

3.3%

Rev. Growth (Qtr)

17.93%

EXPO Earnings

Earnings (TTM)

101.4M

Earnings Growth (Yr)

3.5%

Earnings Growth (Qtr)

44.02%

Breaking Down EXPO Revenue

52 Week Range

84.33101.66
(Low)(High)

Last 7 days

2.1%

Last 30 days

16.4%

Last 90 days

21.4%

Trailing 12 Months

7.2%

How does EXPO drawdown profile look like?

EXPO Financial Health

Current Ratio

3.09

EXPO Investor Care

Dividend Yield

1.12%

Dividend/Share (TTM)

1.06

Buy Backs (1Y)

0.32%

Diluted EPS (TTM)

1.97

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024541.4M000
2023525.1M535.1M541.2M536.8M
2022478.3M488.7M499.4M513.3M
2021410.4M438.3M456.0M466.3M
2020424.1M409.7M406.8M399.9M
2019382.1M393.0M399.2M417.2M
2018360.1M367.9M375.7M379.5M
2017316.0M326.6M336.5M347.8M
2016315.7M313.1M311.7M315.1M
2015309.0M312.3M312.8M312.8M
2014299.5M300.5M303.9M304.7M
2013293.4M294.4M296.3M296.2M
2012270.9M280.3M287.6M292.7M
2011262.8M267.5M267.1M272.4M
20100234.8M241.8M248.8M
2009000227.9M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Exponent Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 07, 2024
rakow joseph
sold
-187,236
94.9956
-1,971
group vice president
May 06, 2024
james bradley a
sold
-335,160
95.00
-3,528
group vice president
May 03, 2024
james bradley a
sold
-519,958
93.7705
-5,545
group vice president
May 02, 2024
james bradley a
sold
-1,209
93.00
-13.00
group vice president
Apr 30, 2024
guyer eric
sold
-152,762
92.5831
-1,650
group vice presient
Mar 13, 2024
reiss richard
acquired
-
-
2,660
group vice president
Mar 13, 2024
reiss richard
sold (taxes)
-104,003
78.79
-1,320
group vice president
Mar 13, 2024
corrigan catherine
acquired
-
-
12,410
president & ceo
Mar 13, 2024
shepard sally
acquired
-
-
5,320
chief human resources officer
Mar 13, 2024
pye john
acquired
-
-
592
group vice president

1–10 of 50

Which funds bought or sold EXPO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 10, 2024
WELLS FARGO & COMPANY/MN
reduced
-10.46
-11,479,000
60,722,600
0.01%
May 10, 2024
PRINCIPAL SECURITIES, INC.
reduced
-25.98
-21,173
48,291
-%
May 10, 2024
Campbell & CO Investment Adviser LLC
sold off
-100
-470,926
-
-%
May 10, 2024
Cynosure Group, LLC
new
-
2,287,450
2,287,450
0.41%
May 10, 2024
Wealth Alliance
reduced
-16.19
-83,883
310,423
0.04%
May 10, 2024
BAHL & GAYNOR INC
sold off
-100
-1,790,640
-
-%
May 10, 2024
CITIGROUP INC
added
1.65
-54,883
1,157,160
-%
May 10, 2024
OSAIC HOLDINGS, INC.
reduced
-98.56
-2,766,940
38,089
-%
May 10, 2024
LPL Financial LLC
reduced
-7.06
-567,376
3,897,040
-%
May 10, 2024
TIAA TRUST, NATIONAL ASSOCIATION
unchanged
-
-21,448
331,504
-%

1–10 of 50

Are Funds Buying or Selling EXPO?

Are funds buying EXPO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own EXPO
No. of Funds

Unveiling Exponent Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Apr 10, 2024
vanguard group inc
10.46%
5,286,652
SC 13G/A
Feb 13, 2024
vanguard group inc
9.87%
4,995,605
SC 13G/A
Feb 13, 2024
kayne anderson rudnick investment management llc
9.23%
4,672,271
SC 13G/A
Feb 12, 2024
neuberger berman group llc
5.20%
2,630,411
SC 13G/A
Jan 23, 2024
blackrock inc.
12.0%
6,079,135
SC 13G/A
Jan 05, 2024
conestoga capital advisors, llc
5.13%
2,596,177
SC 13G/A
Feb 14, 2023
kayne anderson rudnick investment management llc
8.23%
4,168,554
SC 13G/A
Feb 10, 2023
neuberger berman group llc
5.72%
2,897,828
SC 13G/A
Feb 09, 2023
vanguard group inc
11.07%
5,606,880
SC 13G/A
Jan 26, 2023
blackrock inc.
15.8%
8,010,803
SC 13G/A

Recent SEC filings of Exponent Inc

View All Filings
Date Filed Form Type Document
May 07, 2024
144
Notice of Insider Sale Intent
May 07, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading
May 03, 2024
10-Q
Quarterly Report
May 03, 2024
4
Insider Trading
May 02, 2024
144
Notice of Insider Sale Intent
Apr 30, 2024
144
Notice of Insider Sale Intent
Apr 30, 2024
4
Insider Trading
Apr 25, 2024
8-K
Current Report
Apr 22, 2024
DEFA14A
DEFA14A

Peers (Alternatives to Exponent Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
183.3B
69.5B
8.41% 68.26%
52.22
2.64
16.04% -60.91%
173.7B
67.0B
-5.39% 65.06%
15.45
2.59
8.59% 58.17%
40.3B
34.0B
-2.46% 36.67%
19.54
1.18
12.85% -19.64%
39.3B
6.7B
-6.23% 17.43%
29.83
5.84
7.11% 10.53%
12.6B
15.3B
-3.58% 15.85%
-915.55
0.82
13.36% -103.70%
MID-CAP
10.3B
6.9B
-4.99% 68.04%
59.94
1.49
3.19% 62.26%
6.7B
15.5B
-5.91% 44.99%
21.94
0.43
7.53% 3145.00%
6.5B
4.4B
3.46% 38.34%
27.74
1.47
17.31% 1.26%
4.3B
2.4B
5.37% 27.66%
30.01
1.82
4.48% -49.27%
2.4B
1.7B
-10.94% 9.35%
17.71
1.4
8.96% 15.52%
SMALL-CAP
1.5B
1.4B
15.88% -32.78%
25.02
1.04
-13.54% -25.70%
894.9M
573.3M
32.71% 64.84%
27.66
1.56
26.00% -2.24%
786.8M
35.8M
-42.00% -27.50%
-0.83
21.95
-27.93% -18.06%
424.5M
135.4M
5.42% 218.20%
-25.88
3.14
-25.90% 65.37%
257.3M
100.1M
12.78% 412.84%
-31.53
2.57
2.80% 39.07%

Exponent Inc News

Latest updates
Defense World • 6 hours ago
Seeking Alpha • 10 May 2024 • 12:40 pm
Simply Wall St • 23 Apr 2024 • 07:00 am
The Motley Fool • 3 months ago

Exponent Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue17.9%14512313314014012712713012811411612011610399.0092.0010611010210799.00
Operating Expenses9.3%11410599.0011011110590.0085.0092.0090.0084.0091.0092.0086.0078.0083.0070.0089.0078.0082.0083.00
  S&GA Expenses-100.0%-6.006.007.006.007.007.006.004.005.004.003.003.002.003.003.006.005.005.005.005.00
EBITDA Margin2.7%0.28*0.27*0.27*0.27*0.27*0.27*0.27*0.28*0.28*0.28*0.29*0.28*---------
Income Taxes12.3%10.009.009.0011.006.008.009.0010.003.008.008.009.00-0.725.007.005.00-2.238.006.008.001.00
Earnings Before Taxes34.3%40.0030.0034.0036.0036.0031.0033.0035.0033.0029.0032.0035.0030.0027.0025.0021.0024.0027.0025.0029.0023.00
EBT Margin2.7%0.26*0.25*0.25*0.25*0.26*0.26*0.26*0.26*0.27*0.27*0.27*0.27*---------
Net Income44.0%30.0021.0025.0026.0029.0023.0024.0026.0030.0020.0025.0025.0031.0022.0018.0016.0026.0019.0020.0021.0023.00
Net Income Margin0.2%0.19*0.19*0.19*0.19*0.19*0.20*0.20*0.21*0.21*0.22*0.23*0.22*---------
Free Cashflow-87.1%9.0069.0019.0035.00-12.3738.0026.0027.00-8.9653.0024.0042.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-2.7%629647602604566587559567618684638619577580535513484563544521489
  Current Assets-7.2%352380343345318349333343377453418398354367329314293364352335305
    Cash Equivalents-9.9%16918713714812616114816621529823024018519818815610617613310479.00
  Net PPE-1.1%75.0075.0076.0077.0069.0066.0064.0064.0061.0060.0060.0060.0060.0060.0060.0060.0061.0062.0059.0056.0051.00
  Goodwill0%9.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.00
Liabilities-12.2%255291249247225266239229231267233231199219191181160213187177160
  Current Liabilities-29.5%11416213012510915913812810915312612388.0011796.0090.0077.0012410193.0072.00
Shareholder's Equity5.1%374356354357342321320337387417405388378361343333323350357344329
  Retained Earnings2.5%589574567555543529519507493478469455440422410402396385374363351
  Additional Paid-In Capital4.2%335321320317315301299296294281279276274265262260257245243241239
Accumulated Depreciation2.1%106104109--103---------------
Shares Outstanding-0.3%51.0051.0051.0051.0051.0052.0052.0052.0052.0053.0053.0053.00---------
Float----3,400---3,400---3,446---3,092---2,245-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-85.4%10,43271,30922,20140,545-6,70340,57029,42130,168-6,35254,19024,92644,1671,28540,86528,24848,034-13,83555,76627,47437,072-12,253
  Share Based Compensation130.8%7,3403,1804,8915,2237,0634,2924,6054,5976,8704,0244,3654,5926,2823,9523,7263,4626,1383,8813,8444,0105,731
Cashflow From Investing23.4%-1,482-1,934-3,306-5,448-5,668-2,935-3,194-3,308-2,60623,609-26,18828,26912,488-25,83212,32310,8267,70715,9868,470-3,669-16,518
Cashflow From Financing-35.9%-27,227-20,037-29,578-12,654-23,740-25,421-42,020-75,128-73,408-9,987-8,769-16,971-27,026-6,120-9,329-8,582-64,324-28,977-7,200-7,822-19,415
  Dividend Payments-100.0%-13,14913,17713,21714,50012,15312,22512,34512,51410,42310,42110,41911,9359,8399,8089,82010,3088,2808,3248,3068,593
  Buy Backs-24.5%5,4667,23816,970--13,44630,78363,28948,554--7,000----40,049----
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

EXPO Income Statement

2024-03-29
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Revenues:  
Revenues before reimbursements$ 137,207$ 128,705
Reimbursements7,72611,604
Revenues144,933140,309
Operating expenses:  
Compensation and related expenses90,32784,181
Other operating expenses10,5319,561
Reimbursable expenses7,72611,604
General and administrative expenses5,6365,843
Total operating expenses114,220111,189
Operating income30,71329,120
Other income, net:  
Interest income, net2,6261,770
Miscellaneous income (loss), net7,0844,648
Total other income (loss), net9,7106,418
Income before income taxes40,42335,538
Income taxes10,2816,414
Net income$ 30,142$ 29,124
Net income per share:  
Basic (in dollars per share)$ 0.59$ 0.57
Diluted (in dollars per share)$ 0.59$ 0.56
Shares used in per share computations:  
Basic (in shares)51,00651,132
Diluted (in shares)51,41951,682
Cash dividends declared per common share (in dollars per share)$ 0.28$ 0.26

EXPO Balance Sheet

2024-03-29
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 29, 2023
Current assets:  
Cash and cash equivalents$ 168,665$ 187,150
Accounts receivable, net of allowance for contract losses and doubtful accounts of $6,302 and $5,281 at March 29, 2024 and December 29, 2023, respectively162,885167,360
Prepaid expenses and other current assets20,77325,022
Total current assets352,323379,532
Property, equipment and leasehold improvements, net of accumulated depreciation and amortization of $106,162 and $104,011 at March 29, 2024 and December 29, 2023, respectively74,50375,318
Operating lease right-of-use assets24,14524,600
Goodwill8,6078,607
Deferred income taxes52,22453,824
Deferred compensation plan assets113,844101,169
Other assets3,7593,727
Total assets629,405646,777
Current liabilities:  
Accounts payable and accrued liabilities23,92622,125
Accrued payroll and employee benefits68,285111,773
Deferred revenues16,10621,709
Operating lease liabilities5,8146,302
Total current liabilities114,131161,909
Other liabilities3,5803,426
Deferred compensation plan liabilities116,005103,398
Operating lease liabilities21,37821,959
Total liabilities255,094290,692
Stockholders’ equity:  
Common stock, $0.001 par value; 120,000 shares authorized; 65,707 shares issued at March 29, 2024 and December 29, 20236666
Additional paid-in capital335,014321,448
Accumulated other comprehensive loss  
Foreign currency translation adjustments(3,187)(2,977)
Retained earnings588,570574,082
Treasury stock, at cost; 15,033 and 15,134 shares held at March 29, 2024 and December 29, 2023, respectively(546,152)(536,534)
Total stockholders’ equity374,311356,085
Total liabilities and stockholders’ equity$ 629,405$ 646,777
EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
 CEO
 WEBSITEexponent.com
 INDUSTRYApparel Manufacturing
 EMPLOYEES1077

Exponent Inc Frequently Asked Questions


What is the ticker symbol for Exponent Inc? What does EXPO stand for in stocks?

EXPO is the stock ticker symbol of Exponent Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Exponent Inc (EXPO)?

As of Thu May 09 2024, market cap of Exponent Inc is 4.79 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EXPO stock?

You can check EXPO's fair value in chart for subscribers.

What is the fair value of EXPO stock?

You can check EXPO's fair value in chart for subscribers. The fair value of Exponent Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Exponent Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EXPO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Exponent Inc a good stock to buy?

The fair value guage provides a quick view whether EXPO is over valued or under valued. Whether Exponent Inc is cheap or expensive depends on the assumptions which impact Exponent Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EXPO.

What is Exponent Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, EXPO's PE ratio (Price to Earnings) is 47.22 and Price to Sales (PS) ratio is 8.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EXPO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Exponent Inc's stock?

In the past 10 years, Exponent Inc has provided 0.192 (multiply by 100 for percentage) rate of return.